BioSpecifics Technologies Corp (BSTC) Financial Statements (2024 and earlier)

Company Profile

Business Address 35 WILBUR ST
LYNBROOK, NY 11563
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2020
MRQ
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 89,23980,88459,30849,01833,48520,711
Cash and cash equivalents 4,99913,1767,3344,7635,1389,811
Short-term investments 84,24067,70751,97444,25528,34810,900
Receivables 19,06616,5194,6554,3063,4653,640
Capitalized contract cost  185
Deferred costs   1,7941,4521,018570
Other undisclosed current assets 966647624624401228
Total current assets: 109,27198,23466,38155,40038,36925,149
Noncurrent Assets
Operating lease, right-of-use asset 239
Long-term investments and receivables 16,5691,1005,7463,7713,5971,250
Long-term investments 16,5691,1005,7463,7713,5971,250
Intangible assets, net (including goodwill) 573444398258275295
Intangible assets, net (excluding goodwill) 573444398258275295
Deferred costs   7321,9762,8513,271
Other undisclosed noncurrent assets  3141,7403,2906061,062
Total noncurrent assets: 17,3821,8588,6169,2967,3295,878
TOTAL ASSETS: 126,653100,09274,99664,69645,69831,027
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 9981,799934739611544
Taxes payable 355 69   
Employee-related liabilities 209173215183165169
Accrued liabilities 3641,503151517465
Other undisclosed accounts payable and accrued liabilities 70122499505372309
Debt 69     
Deferred revenue and credits1,0581,18014949
Other undisclosed current liabilities 355705147787878
Total current liabilities: 1,4222,5042,1391,997839671
Noncurrent Liabilities
Long-term debt and lease obligation: 167     
Liabilities, other than long-term debt 573 5,3416,4184999
Deferred revenue and credits5,3416,4184999
Deferred income tax liabilities 573
Operating lease, liability 167
Total noncurrent liabilities: 740 5,3416,4184999
Total liabilities: 2,1622,5047,4808,414888770
Equity
Equity, attributable to parent 124,49197,58967,51756,28244,81030,257
Common stock 888877
Treasury stock, value (11,519)(10,898)(7,898)(7,282)(6,233)(4,431)
Additional paid in capital 39,35636,30233,46832,94531,79725,059
Retained earnings 96,64772,17741,93930,61119,2399,621
Total equity: 124,49197,58967,51756,28244,81030,257
TOTAL LIABILITIES AND EQUITY: 126,653100,09274,99664,69645,69831,027

Income Statement (P&L) ($ in thousands)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues 38,18832,96127,44426,25122,75014,077
Revenue, net27,44426,25122,75014,077
Gross profit: 38,18832,96127,44426,25122,75014,077
Operating expenses (9,876)(9,563)(9,766)(9,225)(8,307)(7,877)
Other undisclosed operating income      799
Operating income: 28,31223,39917,67817,02614,4436,999
Nonoperating income 1,9871,39968834910833
Investment income, nonoperating 1,9871,2956372969332
Other nonoperating income (expense) (0)1045153151
Income from continuing operations before income taxes: 30,29924,79718,36617,37514,5517,033
Income tax expense (5,829)(4,744)(7,038)(6,003)(4,933)(2,387)
Income from continuing operations: 24,47020,05311,32811,3729,6184,646
Income before gain (loss) on sale of properties:24,47020,05311,32811,3729,6184,646
Net income available to common stockholders, diluted: 24,47020,05311,32811,3729,6184,646

Comprehensive Income ($ in thousands)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income: 24,47020,05311,32811,3729,6184,646
Comprehensive income, net of tax, attributable to parent: 24,47020,05311,32811,3729,6184,646

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: